Cooper Companies | COO - Ordinary Share Capital


Cooper Companies reported $198.81M in Ordinary Share Capital for its fiscal quarter ending in September of 2025.





Ordinary Share Capital Change Date
Abbott USD 1.74B 23.39B Sep/2025
Align Technology USD 71.75M 736K Dec/2025
AtriCure USD 49.7M 10K Sep/2025
Avanos Medical USD 46.42M 102.94K Sep/2025
Bausch Health Companies USD 370.53M 59K Dec/2025
Baxter International USD 514.28M 168.72M Dec/2025
Bayer EUR 982.42M 0 Sep/2025
Becton, Dickinson and Co. USD 284.91M 1.72M Dec/2025
Boston Scientific USD 1.48B 1.46B Jun/2025
Cooper Companies USD 198.81M 9K Sep/2025
Dentsply International USD 199.5M 196.5M Sep/2025
Dexcom USD 384.8M 5.2M Dec/2025
Edwards Lifesciences USD 580.7M 7.2M Sep/2025
Globus Medical USD 135.05M 134.92M Jun/2025
Haemonetics USD 46.83M 82K Dec/2025
Hologic USD 222.57M 350K Sep/2025
Inogen USD 23K 0 Dec/2023
Insulet USD 70.35M 1000 Dec/2025
Integra LifeSciences USD 77.92M 77M Jun/2025
Intuitive Surgical USD 354.5M 3.98M Dec/2025
J&J USD 2.41B 584K Sep/2025
Medtronic USD 1.28B 116K Sep/2025
Merit Medical Systems USD 59.29M 72K Sep/2025
Novartis USD 1.92B 17.06M Sep/2025
ResMed USD 145.97M 25K Dec/2025
STAAR Surgical USD 49.28M 238K Jun/2025
Steris USD 98.15M 344K Dec/2025
Stryker USD 382.4M 93K Dec/2025
Tandem Diabetes Care USD 68.29M 518K Dec/2025
Teleflex USD 44.19M 482K Jun/2025
Zimmer Biomet Holdings USD 198.18M 18.44K Dec/2025